Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A12104 | 30600551 | J Gastroenterol Hepatol | HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. | 2019 | Details |
A12105 | 30600540 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. | 2019 | Details |
A12106 | 30600304 | Ann Hepatol | The Evolving Role of Liver Biopsy in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
A12107 | 30600295 | Ann Hepatol | Association of Parity in Patients with Chronic Liver Disease. | 2018 | Details |
A12108 | 30599260 | Free Radic Biol Med | Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. | 2018 | Details |
A12109 | 30599172 | J Hepatol | Gap junctions in liver disease: Implications for pathogenesis and therapy. | 2018 | Details |
A12110 | 30598254 | Surg Obes Relat Dis | Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders. | 2018 | Details |
A12111 | 30597715 | Liver Int | Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. | 2019 | Details |
A12112 | 30597691 | Liver Int | The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study. | 2019 | Details |
A12113 | 30597154 | Hum Pathol | Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH. | 2018 | Details |
A12114 | 30596786 | PLoS One | Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. | 2018 | Details |
A12115 | 30595550 | Mol Metab | Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. | 2018 | Details |
A12116 | 33442148 | J ASEAN Fed Endocr Soc | Factors associated with the Severity of Findings on Hepatic Transient Elastography among Persons with Type 2 Diabetes and Fatty Liver. | 2019 | Details |
A12117 | 32864300 | Curr Pharmacol Rep | Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health. | 2019 | Details |
A12118 | 32821461 | Medeni Med J | Evaluation of Liver Biopsy Findings and Comparison with Noninvasive Fibrosis Scores in Patients with Non-Alcoholic Steatohepatitis. | 2019 | Details |
A12119 | 32422008 | Crit Rev Eukaryot Gene Expr | Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound. | 2020 | Details |
A12120 | 32146799 | Pol J Pathol | Green tea extract prevents the development of nonalcoholic liver steatosis in rats fed a high-fat diet. | 2019 | Details |
A12121 | 30594638 | Biochim Biophys Acta Gene Regul Mech | Role of long non-coding RNAs in metabolic control. | 2018 | Details |
A12122 | 30594305 | Cell Immunol | ER-stress regulates macrophage polarization through pancreatic EIF-2alpha kinase. | 2018 | Details |
A12123 | 30593409 | Med Hypotheses | The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. | 2018 | Details |
A12124 | 30592792 | J Diabetes Investig | Insulin-like growth factor-1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus. | 2019 | Details |
A12125 | 30592129 | IUBMB Life | Role of vitamin E in nonalcoholic fatty liver disease. | 2018 | Details |
A12126 | 30591521 | EMBO Mol Med | The role of the microbiome in NAFLD and NASH. | 2019 | Details |
A12127 | 30590942 | Vnitr Lek | Fatty pancreas disease: clinical impact. | 2019 | Details |
A12128 | 30590937 | Vnitr Lek | Transient elastography - role in the assessment of the liver disease development. | 2019 | Details |
A12129 | 30590868 | J Gastroenterol Hepatol | Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. | 2019 | Details |
A12130 | 30590481 | Clin Infect Dis | Discovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water Labeling. | 2019 | Details |
A12131 | 30590197 | J Ethnopharmacol | Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. | 2018 | Details |
A12132 | 30590049 | Cell Rep | OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis. | 2018 | Details |
A12133 | 30589487 | Obes Rev | Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. | 2018 | Details |
A12134 | 30588836 | Antioxid Redox Signal | The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment? | 2019 | Details |
A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
A12136 | 30588203 | Int J Med Sci | No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population. | 2018 | Details |
A12137 | 30588181 | Int J Med Sci | Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
A12138 | 30588150 | Pediatric Health Med Ther | Interventions to improve liver enzyme screening testing in obese patients aged <18 years in a public hospital, Chicago, IL, 2017-2018. | 2018 | Details |
A12139 | 30586008 | J Clin Gastroenterol | Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis. | 2020 | Details |
A12140 | 30585337 | J Clin Pharm Ther | The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2018 | Details |
A12141 | 30584660 | Hepatology | Arid1a Loss Drives Nonalcoholic Steatohepatitis in Mice Through Epigenetic Dysregulation of Hepatic Lipogenesis and Fatty Acid Oxidation. | 2019 | Details |
A12142 | 30584407 | J Med Biochem | Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients? | 2018 | Details |
A12143 | 30583863 | Biochem Biophys Res Commun | Erythropoietin and long-acting erythropoiesis stimulating agent ameliorate non-alcoholic fatty liver disease by increasing lipolysis and decreasing lipogenesis via EPOR/STAT pathway. | 2018 | Details |
A12144 | 30582966 | Biochim Biophys Acta Mol Basis Dis | Prognostic molecular markers in pediatric liver disease - Are there any? | 2018 | Details |
A12145 | 30582898 | Biochem Pharmacol | Developments in bile salt based therapies: A critical overview. | 2018 | Details |
A12146 | 30582862 | Probl Radiac Med Radiobiol | THE EFFECT OF APPLICATION OF ANTIOXIDANT THERAPY IN THE TREATMENT OF NON-ALKOHOLIC STEATOHEPATATIS IN CHORNOBYL NPP ACCIDENT SUFFERERS IN THE REMOTE PERIOD AFTER IRRADIATION. | 2018 | Details |
A12147 | 30582764 | Hepatology | Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression. | 2019 | Details |
A12148 | 30582669 | Hepatology | The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. | 2019 | Details |
A12150 | 30581002 | Biochem Biophys Res Commun | Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1. | 2018 | Details |
A12151 | 30580671 | Lab Anim | The role of gut microbiota in intestinal and liver diseases. | 2018 | Details |
A12152 | 30580553 | Crit Rev Food Sci Nutr | n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. | 2018 | Details |
A12153 | 30580093 | Clin Gastroenterol Hepatol | Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury. | 2018 | Details |
A12154 | 30580090 | Clin Gastroenterol Hepatol | Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation. | 2018 | Details |
A12155 | 30579258 | Biomed Pharmacother | Administration of methyl palmitate prevents non-alcoholic steatohepatitis (NASH) by induction of PPAR-α. | 2018 | Details |
A12156 | 30578967 | Biochim Biophys Acta Mol Cell Biol Lipids | Gut peptide and neuroendocrine regulation of hepatic lipid and lipoprotein metabolism in health and disease. | 2018 | Details |
A12157 | 30578708 | Mol Nutr Food Res | Sulforaphane Improves Lipid Metabolism by Enhancing Mitochondrial Function and Biogenesis In Vivo and In Vitro. | 2019 | Details |
A12158 | 30578586 | J Biophotonics | Raman spectroscopy-based insight into lipid droplets presence and contents in liver sinusoidal endothelial cells and hepatocytes. | 2019 | Details |
A12159 | 30578461 | Adv Exp Med Biol | Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT). | 2019 | Details |
A12160 | 30578029 | Clin Nutr | Higher adherence to plant-based diets are associated with lower likelihood of fatty liver. | 2018 | Details |
A12161 | 30577788 | BMC Bioinformatics | FELLA: an R package to enrich metabolomics data. | 2018 | Details |
A12162 | 30577497 | Int J Mol Sci | Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet. | 2018 | Details |
A12163 | 30577415 | Int J Mol Sci | Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD. | 2018 | Details |
A12164 | 30577089 | Hepatol Res | Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus. | 2019 | Details |
A12165 | 30576936 | Biomed Pharmacother | Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation. | 2018 | Details |
A12166 | 30576769 | Cell Mol Gastroenterol Hepatol | Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A12167 | 30576688 | Metabolism | Surgical management of obesity. | 2018 | Details |
A12168 | 30576537 | Hum Reprod | Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age. | 2019 | Details |
A12169 | 30576354 | PLoS One | Measurement of liver iron by magnetic resonance imaging in the UK Biobank population. | 2018 | Details |
A12170 | 30576330 | PLoS One | Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care. | 2018 | Details |
A12171 | 30576244 | Am J Physiol Endocrinol Metab | Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments. | 2018 | Details |
A12172 | 30574627 | J Gastrointestin Liver Dis | Nonalcoholic Fatty Liver Disease: Status Quo. | 2018 | Details |
A12173 | 30574625 | J Gastrointestin Liver Dis | Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis. | 2018 | Details |
A12174 | 30574460 | Eur Thyroid J | Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria. | 2018 | Details |
A12175 | 30574320 | United European Gastroenterol J | Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. | 2018 | Details |
A12176 | 30574191 | Therap Adv Gastroenterol | Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. | 2018 | Details |
A12177 | 30573812 | Acta Pharmacol Sin | A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters. | 2018 | Details |
A12178 | 30573390 | Lancet Gastroenterol Hepatol | Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study. | 2018 | Details |
A12179 | 30573353 | Clin Nutr | A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease. | 2018 | Details |
A12180 | 30573307 | Nutr Metab Cardiovasc Dis | High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. | 2018 | Details |
A12181 | 30573200 | Arch Med Res | Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models. | 2018 | Details |
A12182 | 30572788 | Biosci Biotechnol Biochem | A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors. | 2018 | Details |
A12183 | 30572631 | Int J Mol Sci | Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model. | 2018 | Details |
A12184 | 30572006 | J Hepatol | Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. | 2018 | Details |
A12185 | 30570529 | J Acquir Immune Defic Syndr | Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study. | 2019 | Details |
A12187 | 30569636 | Obesity (Silver Spring) | Blackcurrant (Ribes nigrum) Prevents Obesity-Induced Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
A12188 | 30569183 | Eur Radiol | CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard. | 2018 | Details |
A12189 | 30568947 | World J Clin Cases | Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions. | 2018 | Details |
A12190 | 30568471 | Diabetes Metab Syndr Obes | Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis. | 2018 | Details |
A12191 | 30568387 | World J Gastroenterol | Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model. | 2018 | Details |
A12192 | 30568000 | Biochem J | ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARα. | 2019 | Details |
A12193 | 30567742 | Gut | Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease. | 2018 | Details |
A12194 | 30567393 | Int J Mol Sci | Tunicamycin-Induced ER Stress is Accompanied with Oxidative Stress via Abrogation of Sulfur Amino Acids Metabolism in the Liver. | 2018 | Details |
A12195 | 30567368 | Int J Mol Sci | Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil. | 2018 | Details |
A12196 | 30567081 | BMJ Case Rep | Non-alcoholic steatohepatitis associated with Netherton syndrome. | 2018 | Details |
A12197 | 30566676 | J Clin Endocrinol Metab | Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content. | 2019 | Details |
A12198 | 30566427 | PLoS Biol | Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis. | 2018 | Details |
A12200 | 30564426 | R Soc Open Sci | Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. | 2018 | Details |
A12201 | 30564000 | J Clin Exp Hepatol | Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A12202 | 30563997 | J Clin Exp Hepatol | Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors. | 2018 | Details |
A12204 | 30563142 | Molecules | Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. | 2018 | Details |
A12205 | 30562976 | J Clin Med | Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. | 2018 | Details |
A12206 | 30562559 | Biochim Biophys Acta Mol Basis Dis | Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. | 2018 | Details |
A12207 | 30561388 | J Clin Invest | STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. | 2018 | Details |